Wall Street sees multi-billion dollar debut for Lilly’s obesity pill
TimesLive | 02.04.2026 19:29
Eli Lilly’s newly approved weight-loss pill is expected to generate billions in sales as soon as this year, with analysts betting it will quickly narrow Novo Nordisk’s head start in the oral market.
